+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The vaccine adverse event reporting system and vaccine safety research in the genomics era



The vaccine adverse event reporting system and vaccine safety research in the genomics era



Vaccine 30(6): 1162-1164



Advances in genetics hold promise for integrating genomics into vaccine safety research. Given the rarity of many vaccine adverse effects, and the challenges in finding sufficient numbers of patients to study, consideration should be given to employing the Vaccine Adverse Event Reporting System (VAERS) for genetic studies of vaccine adverse events. VAERS could be used to build a repository of biospecimens allowing for the systematic evaluation of vaccine adverse events. If successful, such research would enable the identification of specific subgroups of people at particularly increased risk for adverse events.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056531408

Download citation: RISBibTeXText

PMID: 22178101

DOI: 10.1016/j.vaccine.2011.12.018


Related references

Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014-2017. Vaccine 2019, 2019

Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiology and Drug Safety 11(3): 189-202, 2002

Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety. Pediatrics 127(Suppl. 1): S39-S44, 2011

Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system. Vaccine 30(11): 2020-2023, 2012

Safety of anthrax vaccine A review by the Anthrax Vaccine Expert Committee of adverse events reported to the Vaccine Adverse Event Reporting System. Pharmacoepidemiology & Drug Safety 11(3): 189-202, 2002

Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiology and Drug Safety 13(12): 825-840, 2004

Safety of quadrivalent human papillomavirus vaccine (Gardasil) in pregnancy: adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013. Vaccine 33(4): 519-522, 2015

Comparative safety of two recombinant hepatitis B vaccines in children: Data from the vaccine adverse event reporting system (VAERS) and vaccine safety datalink (VSD). Journal of Clinical Epidemiology 51(6): 503-510, 1998

The safety of the hepatitis A vaccine Data from the vaccine adverse event reporting system. Clinical Infectious Diseases 25(2): 466, 1997

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatric Infectious Disease Journal 23(4): 287-294, 2004

The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety. Pediatric Annals 33(9): 599-606, 2004

Safety data on meningococcal polysaccharide vaccine from the Vaccine Adverse Event Reporting System. Clinical Infectious Diseases 32(9): 1273-1280, 2001

Vaccine-adverse event reporting system: an essential tool for monitoring vaccine safety. Journal of the American Pharmacists Association 46(2): 298-299, 2006

Lyme vaccine safety data reported to the vaccine adverse event reporting system of the USA from the first year of use. Pharmacoepidemiology & Drug Safety 9(Suppl. 1): S61-S62, 2000

Two-year review of hepatitis A vaccine safety: data from the Vaccine Adverse Event Reporting System (VAERS). Clinical Infectious Diseases 26(6): 1475-1476, 1998